What's new

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 28, Status: Authorised

May 27, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 28, Status: Authorised
Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 28, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Galafold, migalastat, ...

Next Article

Human medicines European public assessment report (EPAR): Eucreas, vildagliptin,...

Related Posts

European Union example instances - E2B(R3) testing files

May 23, 2025  0

Human medicines European public assessment report (EPAR): Itovebi, inavolisib, Status: Opinion

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0